Announcements

Cyngn Inc. filed Definitive Additional Materials (DEFA14A) on October 30, 2026, supplementing its 2026 Annual Meeting proxy statement to disclose that director Karen Macleod has withdrawn as a nominee for re-election at the November 3, 2026 Annual Meeting of Stockholders.

Vistagen Therapeutics, Inc. filed a Form 8-K on October 30, 2026, disclosing a Board-approved reduction in workforce of approximately 31%, effective October 26, 2026, with estimated severance costs of approximately $1.0 million and projected annual salary and benefits savings of approximately $3.2 million.

Visium Technologies, Inc. filed a Form 8-K on October 30, 2026, disclosing the October 26, 2026 resignation of Paul R. Taylor as Chairman of the Board, Chief Executive Officer, and director, and the subsequent designation of Mark B. Lucky as interim principal executive officer …

Blue Owl Capital Inc. filed its quarterly report on Form 10-Q with the SEC on October 30, 2026, covering the period ended September 30, 2026, disclosing share counts, platform definitions, and business developments for the alternative asset management firm.

SHF Holdings, Inc. filed a Form 8-K on October 30, 2026, disclosing the unregistered issuance of 60,570,250 shares of Class A Common Stock upon the conversion of Series B Convertible Preferred Stock between October 24 and October 30, 2026.

Jennifer Tejada, Executive Chair and Director of PagerDuty, Inc., filed a Form 4 on October 30, 2026, reporting a stock option exercise and a sale of common stock executed on October 28, 2026, under a pre-established Rule 10b5-1 trading plan.

Robinhood Markets, Inc. filed a Form 4 on October 30, 2026, disclosing a sale of 124,319 common shares of beneficial interest in Robinhood Ventures Fund I (RVI) on October 28, 2026, at a price of $24.77 per share.